Reduced complication-related costs and enhanced patient recovery using the Ezisurg Endostapler
Bariatric and metabolic surgery (BMS) using the easyEndo™ Lite Endostapler (Ezisurg Medical) results in low rates of postoperative...
top of page
Headlines
Preoperative antihypertensive drugs and visceral fat area can predict hypertension remission and recurrence post-LSG
By combining the number of preoperative antihypertensive drugs (ADs) and visceral fat area (VFA) may help predict hypertension (HTN)...
Research
Preoperative antihypertensive drugs and visceral fat area can predict hypertension remission and recurrence post-LSG
By combining the number of preoperative antihypertensive drugs (ADs) and visceral fat area (VFA) may help predict hypertension (HTN)...
Muscle-preserving weight loss drug ASC47 plus semaglutide is superior to semaglutide monotherapy for weight loss
Ascletis Pharma has revealed in a head-to-head diet-induced obese (DIO) mouse study, ASC47 low dose combination 1 (ASC47, 3 mg/kg,...
Racial and ethnic groups face barriers to obtaining OMMs
Asians, non-Hispanic Blacks and Hispanics were significantly less likely than whites to use obesity-management medications (OMMs) to...
Survey finds 50% of post-bariatric surgery patients feel less stress during the holidays
About 50% of bariatric patients reported experiencing significantly less or less stress during the holidays compared to the holiday...
Journal Watch 18/12/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
True You Weight Loss to initiate two clinical trials assessing gastric fundal mucosal ablation
True You Weight Loss, a dedicated endobariatric weight loss center, has announced two new FDA-authorised clinical trials aimed at...
Obesity-related brain changes can be reversed after bariatric surgery
Higher calorie foods were preferred among individuals living with and without obesity despite similar taste and texture, according to a...
Verge Genomics reveals VRG201 as its candidate for long-term weight management and metabolic homeostasis
Verge Genomics has nominated a second development candidate, VRG201, targeting long-term weight management and metabolic homeostasis....
Structure Therapeutics selects oral small molecule amylin receptor agonist ACCG-2671 for obesity treatment
Structure Therapeutics has selected its lead oral small molecule amylin receptor agonist, ACCG-2671, which the company will develop for...
Reduced complication-related costs and enhanced patient recovery using the Ezisurg Endostapler
Bariatric and metabolic surgery (BMS) using the easyEndo™ Lite Endostapler (Ezisurg Medical) results in low rates of postoperative...
Fractyl unveils promising preclinical data demonstrating safety and feasibility of local delivery of RJVA-001 Rejuva Smart GLP-1 Pancreatic Gene Therapy
Fractyl Health has presented new data from its preclinical Rejuva Smart GLP-1 pancreatic gene therapy program in a poster titled,...
Researchers to develop BIOSYNC wireless bioelectronic device to treat obesity and diabetes
A multidisciplinary team led by Ken Shepard, a pioneering researcher in bioelectronics at Columbia Engineering, has won an award of up to...
Industry
All caught up?
New: Directory
Discover global suppliers of specialist bariatric services, treatments, products, and medical equipment.
Events
Tweets
bottom of page